165 related articles for article (PubMed ID: 58409)
1. Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67.
van de Poll MA; Versluis A; Rasker JJ; Jurjens H; Woldring MG
Nuklearmedizin; 1976 Apr; 15(2):86-90. PubMed ID: 58409
[TBL] [Abstract][Full Text] [Related]
2. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
Zimmermann M; Hale T
Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
[TBL] [Abstract][Full Text] [Related]
3. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
[TBL] [Abstract][Full Text] [Related]
4. Iodinated bleomycin: an unsatisfactory radiopharmaceutical for tumor localization.
Eckelman WC; Kubota H; Siegel BA; Komai T; Rzeszotarski WJ; Reba RC
J Nucl Med; 1976 May; 17(5):385-8. PubMed ID: 57231
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of the concentration of tumor tracers in non-malignant lesions.
De Roo MJ
J Nucl Biol Med; 1975; 19(1):5-11. PubMed ID: 49412
[No Abstract] [Full Text] [Related]
6. Chemical and biologic properties of isolated radiolabeled bleomycin preparations.
Eckelman WC; Rzeszotarski WJ; Siegel BA; Kubota H; Chelliah M; Stevenson J; Rebra RC
J Nucl Med; 1975 Nov; 16(11):1033-7. PubMed ID: 52699
[TBL] [Abstract][Full Text] [Related]
7. [Positive tumor scintigraphy. I. Pharmacokinetics of 111In and 57Co bleomycin].
Blottner A; Deckart H; Weiland J
Radiobiol Radiother (Berl); 1978 Jun; 19(3):365-77. PubMed ID: 82976
[No Abstract] [Full Text] [Related]
8. Gallium-67 citrate scanning in malignant lymphoma.
Henkin RE
CRC Crit Rev Clin Radiol Nucl Med; 1975 Nov; 7(1):65-96. PubMed ID: 53117
[No Abstract] [Full Text] [Related]
9. Radiolabeled antitumor agents.
Goodwin DA; Meares CF
Semin Nucl Med; 1976 Oct; 6(4):389-96. PubMed ID: 62401
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of phase 1 clinical testing of a kit for labelling bleomycin with cobalt 57Co].
Brousil J; Svihovcová P; Seblová J; Raban P
Sb Lek; 1986; 88(4-5):97-102. PubMed ID: 2425410
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.
Grove RB; Reba RC; Eckelman WC; Goodyear M
J Nucl Med; 1974 Jun; 15(6):386-90. PubMed ID: 4133503
[No Abstract] [Full Text] [Related]
12. [Detection of intrathoracic malignant tumors using labeled metals].
Blanchon P; Raynaud C
Poumon Coeur; 1974; 30(4):249-55. PubMed ID: 4465787
[No Abstract] [Full Text] [Related]
13. [Achievements and perspectives of radioisotope diagnosis of malignant tumors (according to materials in the "Journal of Nuclear Medicine", 1974)].
Zherbin EA; Fateeva MN
Med Radiol (Mosk); 1976 Jan; 21(1):79-84. PubMed ID: 59300
[No Abstract] [Full Text] [Related]
14. Clinical evaluation of radio-labelled bleomycin for tumor detection.
Rasker JJ; Beekhuis H; van de Poll MA; Versluis A; Jurjens H; Woldring MG
Nuklearmedizin; 1978 Dec; 17(6):238-48. PubMed ID: 84374
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of liver metastases with a combination of 57Co-bleomycin and 99mTc-sulfur colloid].
Haubold U
Strahlentherapie Sonderb; 1975; 74():490-5. PubMed ID: 53915
[No Abstract] [Full Text] [Related]
16. Kinetics of 111In-bleomycin and 111 In-chlorides in mice.
Konikowski T; Haynie TP; Glenn HJ
J Nucl Med; 1975 Aug; 16(8):738-43. PubMed ID: 51922
[TBL] [Abstract][Full Text] [Related]
17. Letter: Brain tumor scanning agents.
Sear R
J Nucl Med; 1976 May; 17(5):418-9. PubMed ID: 1262952
[No Abstract] [Full Text] [Related]
18. Radioactive colloidal solutions and suspensions for medical use.
Mikheev NB
At Energy Rev; 1976 Mar; 14(1):3-36. PubMed ID: 782479
[TBL] [Abstract][Full Text] [Related]
19. Brain tumor-scanning agents compared in an animal model.
Konikowski T; JPAHNS MF; Haynie P; Glenn HJ
J Nucl Med; 1975 Mar; 16(3):200-7. PubMed ID: 46273
[TBL] [Abstract][Full Text] [Related]
20. Extensive chemical degradation of bleomycin during attempted labelling with 51-Cr.
Areberg J; Björkman S
Nuklearmedizin; 1999; 38(4):120-3. PubMed ID: 10392377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
